URL goes live when the embargo lifts
In May 2022, the first case of MPXV infection in the United States in the current global outbreak was identified. Until the case patient was identified as a person under investigation for monkeypox, he received care in many locations without specific precautions. As part of the public health and health care facility response, a contact tracing and exposure investigation was done.
Researchers from Massachusetts General Hospital, Beth Israel Lahey Health and the Massachusetts Department of Public Health describe a framework of contact tracing, exposure identification, risk stratification, administration of PEP, and exposure period monitoring for contacts of the index patient, including evaluation of persons who developed symptoms possibly consistent with MPXV infection. Those with high-risk exposures were offered PEP, and 3 elected to have it. Among those with intermediate-risk exposures for which PEP was offered as part of informed clinical decision making, 2 elected to receive PEP. No transmissions were identified at the conclusion of the 21-day monitoring period, despite the delay in recognition of monkeypox in the index patient. Public health authorities and health care facilities should consider how these findings may inform revised estimates of exposure risk, requirements for monitoring, and recommendations for PEP.
Media contacts: For an embargoed PDF, please contact Addison Dunlap at [email protected]. To speak with an author, please contact:
- Noah Brown, MGH, at [email protected]
- Teresa Herbert, BILH, at [email protected]
- Alison Cohen, Massachusetts Department of Public Health, at [email protected].